PALIPERIDONE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43975-351 -
Package NDC
43975-351-03 -
Application number
ANDA204452 -
SPL ID
57a9842e-b847-e3c7-e063-6294a90af4fc -
SPL set ID
bbbaa057-f587-4eb9-a0d2-463dbcd57661 -
UNII
838F01T721 -
RxCUI
672567 -
RxCUI
672569 -
RxCUI
672571 -
RxCUI
866103
What the source publishes
- Labeler
- ANI Pharmaceuticals, Inc.
- Active ingredients
- PALIPERIDONE
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "PALIPERIDONE",
"splId": "57a9842e-b847-e3c7-e063-6294a90af4fc",
"labels": [
{
"setId": "bbbaa057-f587-4eb9-a0d2-463dbcd57661",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbbaa057-f587-4eb9-a0d2-463dbcd57661",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bbbaa057-f587-4eb9-a0d2-463dbcd57661"
}
],
"routes": [
"ORAL"
],
"labeler": "ANI Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43975-351-03)",
"package_ndc": "43975-351-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20191127"
}
],
"productId": "43975-351_57a9842e-b847-e3c7-e063-6294a90af4fc",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "43975-351",
"deaSchedule": null,
"genericName": "PALIPERIDONE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PALIPERIDONE",
"strength": "6 mg/1"
}
],
"applicationNumber": "ANDA204452",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20191127",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175430"
],
"upc": [
"0343975352034",
"0343975350030",
"0343975349034",
"0343975351037"
],
"unii": [
"838F01T721"
],
"rxcui": [
"672567",
"672569",
"672571",
"866103"
],
"spl_set_id": [
"bbbaa057-f587-4eb9-a0d2-463dbcd57661"
],
"pharm_class_epc": [
"Atypical Antipsychotic [EPC]"
],
"manufacturer_name": [
"ANI Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43975-351_57a9842e-b847-e3c7-e063-6294a90af4fc"